Publications by authors named "Hong Lin Tan"

Claim this Profile
A
A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair.
Monica Florio, Kannan Gunasekaran, Marina Stolina, Xiaodong Li, Ling Liu, Hong Lin Tan

Nat Commun· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene.
Chaoyang Li, Michael S Ominsky, Hong-Lin Tan, Mauricio Barrero, Qing-Tian Niu

Bone· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury.
Xiaodong Li, Mario Grisanti, Wei Fan, Frank J Asuncion, Hong-Lin Tan

J Bone Miner Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Xiaodong Li, Michael S Ominsky, Marina Stolina, Kelly S Warmington, Zhaopo Geng, Hong-Lin Tan

Bone· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL.
Paul J Kostenuik, Hung Q Nguyen, James McCabe, Kelly S Warmington, Carol Kurahara, Hong Lin Tan

J Bone Miner Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
Michael S Ominsky, Xiaodong Li, Frank J Asuncion, Mauricio Barrero, Kelly S Warmington, Hong-Lin Tan

J Bone Miner Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.
Sean Morony, Kelly Warmington, Stephen Adamu, Frank Asuncion, Zhaopo Geng, Hong Lin Tan, Colin R Dunstan

Endocrinology· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis